The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 23, 2010
Filed:
Oct. 24, 2005
Toyokazu Seki, Tokushima, JP;
Takayuki Shiratsuchi, Tokushima, JP;
Osamu Ogawa, Kyoto, JP;
Seiji Naito, Fukuoka, JP;
Taiji Tsukamoto, Sapporo, JP;
Hiroshi Toma, Shinjuku-ku, JP;
Yoshihiko Hirao, Kashihara, JP;
Susumu Kagawa, Tokushima, JP;
Yoshiaki Nose, Fukuoka, JP;
Tsuyoshi Nakamura, Nagasaki, JP;
Toyokazu Seki, Tokushima, JP;
Takayuki Shiratsuchi, Tokushima, JP;
Osamu Ogawa, Kyoto, JP;
Seiji Naito, Fukuoka, JP;
Taiji Tsukamoto, Sapporo, JP;
Hiroshi Toma, Shinjuku-ku, JP;
Yoshihiko Hirao, Kashihara, JP;
Susumu Kagawa, Tokushima, JP;
Yoshiaki Nose, Fukuoka, JP;
Tsuyoshi Nakamura, Nagasaki, JP;
Otsuka Pharmaceutical Co., Ltd., Tokyo, JP;
Abstract
The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a patient with renal cell cancer, analyzing the DNA sequence of the genomic DNA or the complementary strand thereof to determine the gene polymorphism of the human gene, and evaluating the tumor-suppression effect of IFN therapy on renal cell cancer by using the polymorphism as an indicator.